These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The use of bisphosphonates in children with osteogenesis imperfecta. Glorieux FH. J Pediatr Endocrinol Metab; 2001 Jan; 14 Suppl 6():1491-5. PubMed ID: 11837505 [Abstract] [Full Text] [Related]
26. [Regeneration of the cranial vault bones]. Matlosz Z. Pol Tyg Lek; 1970 Nov; 25(47):1819-22. PubMed ID: 4921988 [No Abstract] [Full Text] [Related]
27. Observation on the surgical management of osteogenesis imperfecta. Millar EA. Clin Orthop Relat Res; 1981 Sep; (159):154-6. PubMed ID: 7285453 [Abstract] [Full Text] [Related]
28. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series. Schwartz S, Joseph C, Iera D, Vu DD. J Can Dent Assoc; 2008 Sep; 74(6):537-42. PubMed ID: 18644240 [Abstract] [Full Text] [Related]
30. [Role of the bone mineral density investigation through measuring of peripheral dual-energetic x-ray absorption in prevention of fractures in children with osteogenesis imperfecta]. Saganelidze KhZ. Georgian Med News; 2005 Mar; (120):61-4. PubMed ID: 15855703 [Abstract] [Full Text] [Related]
31. Osteogenesis imperfecta: results obtained with the Sofield method of surgical treatment. Dal Monte A, Manes E, Capanna R, Andrisano A. Ital J Orthop Traumatol; 1982 Mar; 8(1):43-52. PubMed ID: 7174283 [Abstract] [Full Text] [Related]
37. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. DiMeglio LA, Ford L, McClintock C, Peacock M. Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028 [Abstract] [Full Text] [Related]
39. Treatment of poor linear growth in a patient with osteogenesis imperfecta type III. Robinson RF, Long LD, Mahan JD. Clin Ther; 2004 Oct; 26(10):1680-3. PubMed ID: 15598484 [Abstract] [Full Text] [Related]